hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 7.10
-0.05 (-0.70%)
Jul 6, 2026, 4:35 PM GMT
hVIVO Market Cap
hVIVO has a market cap or net worth of 49.12 million as of July 6, 2026. Its market cap has decreased by -31.89% in one year.
Market Cap
49.12M
Enterprise Value
49.61M
Revenue
49.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.10
Market Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 49.12M, an increase of 184.97%. That is a compound annual growth rate of 16.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 49.12M | 14.60% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 94.23M |
| Bioventix | 83.60M |
| 4basebio | 81.58M |
| Ondine Biomedical | 77.41M |
| Hemogenyx Pharmaceuticals | 52.36M |
| Poolbeg Pharma | 48.30M |
| Sareum Holdings | 29.10M |
| SkinBioTherapeutics | 27.21M |